Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESEl martes, 4 de junio, se llevó a cabo la Jornada de Farmacia Hospitalaria, organizada por Diariofarma en colaboración con IQVIA y la SEFH. Este año se tituló ‘Innovación, retos sanitarios, regulatorios y económicos’ y contó con la asistencia de 40 profesionales.
El evento fue presentado por Concha Almarza junto a José María López, director de Diariofarma y Miguel Ángel Calleja, presidente de la SEFH.
Concha comentó que la innovación no solo se debe abordar desde el punto de vista de nuevos medicamentos, sino que se deben tomar en cuenta las nuevas técnicas de diagnóstico, canales, tecnologías y cambios en el paciente.
Isabel Ricote presentó una charla sobre la perspectiva del pipeline en oncología y expresó que en el consumo de fármacos lidera la oncología con un crecimiento del 29%.
Actualmente, hay 849 moléculas en fases avanzadas en investigación en oncología, la mayoría para terapias dirigidas o inmuno-oncología. “Esta cantidad de moléculas supone un horizonte esperanzador para los pacientes, pero un reto para todos los agentes implicados en la sanidad”, afirmó Ricote.
En la jornada también se llevó a cabo una mesa redonda en la que 4 profesionales de la Farmacia Hospitalaria profundizaron en diferentes aspectos sobre la innovación en este ámbito.